BMO Capital Starts Constellation Pharmaceuticals (CNST) at Outperform
Tweet Send to a Friend
BMO Capital analyst Do Kim initiates coverage on Constellation Pharmaceuticals (NASDAQ: CNST) with a Outperform rating and ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE